Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BDH1 Antikörper

BDH1 Reaktivität: Human, Maus WB, ELISA, IHC Wirt: Maus Monoclonal 1A5 unconjugated
Produktnummer ABIN1724721
  • Target Alle BDH1 Antikörper anzeigen
    BDH1 (3-hydroxybutyrate Dehydrogenase, Type 1 (BDH1))
    Reaktivität
    • 33
    • 4
    • 2
    • 2
    Human, Maus
    Wirt
    • 30
    • 5
    Maus
    Klonalität
    • 32
    • 3
    Monoklonal
    Konjugat
    • 14
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser BDH1 Antikörper ist unkonjugiert
    Applikation
    • 31
    • 14
    • 13
    • 13
    • 13
    • 7
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
    Aufreinigung
    purified
    Immunogen
    Purified recombinant fragment of human BDH1 expressed in E. coli.
    Klon
    1A5
    Isotyp
    IgG1
  • Applikationshinweise
    ELISA: 1:10000, WB: 1:500 - 1:2000, IHC: 1:200 - 1:1000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    4°C, -20°C for long term storage
  • Chang, Olson, Schwartz: "Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy." in: Nutrition & metabolism, Vol. 10, Issue 1, pp. 47, (2013) (PubMed).

    Xu, Huang, Xu, Qian, Zhu, Yan, Cai, Zhang, Xiao, Qu, Liu, Huang, Cheng, Li, Du, Hu, Shen, Lu, Fu, Zhong, Xu, Gu, Huang, Zhao, Hu, Gu, Chen, Han: "Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 26, pp. 15089-94, (2001) (PubMed).

    Loeb-Hennard, McIntyre: "(R)-3-hydroxybutyrate dehydrogenase: selective phosphatidylcholine binding by the C-terminal domain." in: Biochemistry, Vol. 39, Issue 39, pp. 11928-38, (2000) (PubMed).

  • Target
    BDH1 (3-hydroxybutyrate Dehydrogenase, Type 1 (BDH1))
    Andere Bezeichnung
    BDH1 (BDH1 Produkte)
    Synonyme
    zgc:163053 antikoerper, BDH antikoerper, SDR9C1 antikoerper, 2310032J20Rik antikoerper, AI327223 antikoerper, Bdh antikoerper, 3-hydroxybutyrate dehydrogenase 1 antikoerper, 3-hydroxybutyrate dehydrogenase 1 S homeolog antikoerper, 3-hydroxybutyrate dehydrogenase, type 1 antikoerper, 3-hydroxybutyrate dehydrogenase, type 1 A antikoerper, BDH1 antikoerper, bdh1.S antikoerper, bdh1 antikoerper, Bdh1 antikoerper, BDH1A antikoerper
    Hintergrund

    Description: BDH1 (3-hydroxybutyrate dehydrogenase, type 1), it is a member of the short-chain dehydrogenase/reductase gene family. This protien forms a homotetrameric lipid-requiring enzyme of the mitochondrial membrane and has a specific requirement for phosphatidylcholine for optimal enzymatic activity. It catalyzes the interconversion of acetoacetate and (R)-3-hydroxybutyrate, the two major ketone bodies produced during fatty acid catabolism.

    Aliases: BDH

    Molekulargewicht
    38 kDa
    Gen-ID
    622
    HGNC
    622
    Pathways
    Response to Growth Hormone Stimulus
Sie sind hier:
Kundenservice